Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zileuton CR Bronchodilation in Stable Chronic Asthma
NCT01805687Phase 4Completed
- Sponsor
- Cornerstone Therapeutics
- Start
- Mar 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zileuton extended release in asthma, sponsored by Cornerstone Therapeutics. Primary endpoint: Change From Baseline in FEV1 at 12 hours. Started Mar 2013; status: completed.
02
Drugs
zileuton extended release
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01805687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01805687.